Belal A - Search Results

1

Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma.

Eissa IH, Ibrahim MK, Metwaly AM, Belal A, Mehany ABM, Abdelhady AA, Elhendawy MA, Radwan MM, ElSohly MA, Mahdy HA. Eissa IH, et al. Among authors: belal a. Bioorg Chem. 2021 Feb;107:104532. doi: 10.1016/j.bioorg.2020.104532. Epub 2020 Dec 8. Bioorg Chem. 2021. PMID: 33334586

2

Synthesis, anti-breast cancer activity, and molecular modeling of some benzothiazole and benzoxazole derivatives.

Abdelgawad MA, Belal A, Omar HA, Hegazy L, Rateb ME. Abdelgawad MA, et al. Among authors: belal a. Arch Pharm (Weinheim). 2013 Jul;346(7):534-41. doi: 10.1002/ardp.201300044. Epub 2013 Jun 5. Arch Pharm (Weinheim). 2013. PMID: 23740859

3

Design, synthesis and biological evaluation of novel triaryl (Z)-olefins as tamoxifen analogues.

Abdellatif KR, Belal A, Omar HA. Abdellatif KR, et al. Among authors: belal a. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4960-3. doi: 10.1016/j.bmcl.2013.06.056. Epub 2013 Jun 26. Bioorg Med Chem Lett. 2013. PMID: 23860592

4

Pyrrolizines: Promising scaffolds for anticancer drugs.

Belal A, El-Gendy Bel-D. Belal A, et al. Bioorg Med Chem. 2014 Jan 1;22(1):46-53. doi: 10.1016/j.bmc.2013.11.040. Epub 2013 Dec 1. Bioorg Med Chem. 2014. PMID: 24331756 Review.

5

Design, synthesis and anticancer activity evaluation of some novel pyrrolo[1,2-a]azepine derivatives.

Belal A. Belal A. Arch Pharm (Weinheim). 2014 Jul;347(7):515-22. doi: 10.1002/ardp.201400004. Epub 2014 Apr 14. Arch Pharm (Weinheim). 2014. PMID: 24729464

6

Synthesis, molecular docking and antitumor activity of novel pyrrolizines with potential as EGFR-TK inhibitors.

Belal A. Belal A. Bioorg Chem. 2015 Apr;59:124-9. doi: 10.1016/j.bioorg.2015.02.006. Epub 2015 Feb 21. Bioorg Chem. 2015. PMID: 25748126

7

Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.

Ahmed MF, Belal A. Ahmed MF, et al. Among authors: belal a. Arch Pharm (Weinheim). 2015 Jul;348(7):487-97. doi: 10.1002/ardp.201400468. Epub 2015 Apr 29. Arch Pharm (Weinheim). 2015. PMID: 25921702

8

Design, synthesis, biological evaluations, molecular docking, and in vivo studies of novel phthalimide analogs.

Zahran MAH, El-Aarag B, Mehany ABM, Belal A, Younes AS. Zahran MAH, et al. Among authors: belal a. Arch Pharm (Weinheim). 2018 May;351(5):e1700363. doi: 10.1002/ardp.201700363. Epub 2018 Apr 3. Arch Pharm (Weinheim). 2018. PMID: 29611624

9

Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction.

Belal A. Belal A. Anticancer Agents Med Chem. 2018;18(15):2124-2130. doi: 10.2174/1871520618666180409155520. Anticancer Agents Med Chem. 2018. PMID: 29629667

10

Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.

Ammar YA, Sh El-Sharief AM, Belal A, Abbas SY, Mohamed YA, Mehany ABM, Ragab A. Ammar YA, et al. Among authors: belal a. Eur J Med Chem. 2018 Aug 5;156:918-932. doi: 10.1016/j.ejmech.2018.06.061. Epub 2018 Jun 28. Eur J Med Chem. 2018. PMID: 30096580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters